In vitro, we have shown that PP2A activators inhibit cytokine production in a cellular model of airway inflammation using A549 lung epithelial cells stimulated with tumor necrosis factor (TNF) in vitro4, 5. This evidence concerns the gene TNF and inflammatory response.